Fate Therapeutics Inc (FATE)
4.06
-0.04
(-0.98%)
USD |
NASDAQ |
May 03, 16:00
4.06
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Cash and Short Term Investments (Quarterly): 315.18M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 315.18M |
| September 30, 2023 | 349.73M |
| June 30, 2023 | 377.94M |
| March 31, 2023 | 408.90M |
| December 31, 2022 | 436.23M |
| September 30, 2022 | 505.14M |
| June 30, 2022 | 568.85M |
| March 31, 2022 | 573.77M |
| December 31, 2021 | 615.91M |
| September 30, 2021 | 678.70M |
| June 30, 2021 | 695.60M |
| March 31, 2021 | 790.14M |
| December 31, 2020 | 482.92M |
| September 30, 2020 | 488.80M |
| June 30, 2020 | 533.41M |
| March 31, 2020 | 203.28M |
| December 31, 2019 | 221.43M |
| September 30, 2019 | 302.82M |
| June 30, 2019 | 162.01M |
| March 31, 2019 | 183.03M |
| December 31, 2018 | 201.01M |
| September 30, 2018 | 211.19M |
| Date | Value |
|---|---|
| June 30, 2018 | 78.02M |
| March 31, 2018 | 88.63M |
| December 31, 2017 | 100.95M |
| September 30, 2017 | 69.21M |
| June 30, 2017 | 71.01M |
| March 31, 2017 | 82.30M |
| December 31, 2016 | 92.11M |
| September 30, 2016 | 46.62M |
| June 30, 2016 | 45.93M |
| March 31, 2016 | 55.61M |
| December 31, 2015 | 64.81M |
| September 30, 2015 | 72.86M |
| June 30, 2015 | 81.18M |
| March 31, 2015 | 42.35M |
| December 31, 2014 | 49.10M |
| September 30, 2014 | 45.53M |
| June 30, 2014 | 42.01M |
| March 31, 2014 | 47.88M |
| December 31, 2013 | 54.04M |
| September 30, 2013 | 19.08M |
| June 30, 2013 | 3.399M |
| December 31, 2012 | 9.087M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
162.01M
Minimum
Jun 2019
790.14M
Maximum
Mar 2021
458.46M
Average
482.92M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 286.20M |
| Sarepta Therapeutics Inc | 1.391B |
| ADMA Biologics Inc | 51.35M |
| Ocular Therapeutix Inc | 195.81M |
| Viking Therapeutics Inc | 962.98M |